OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced that it has completed the previously announced sale of TachoSil®&nb…
Takeda Completes Sale of TachoSil® to Corza Health
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced that it has completed the previously announced sale of TachoSil®&nb…